» Articles » PMID: 15718844

Changes over Time in Post-seroconversion CD4 Cell Counts in the Italian HIV-Seroconversion Study: 1985-2002

Overview
Journal AIDS
Date 2005 Feb 19
PMID 15718844
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether there has been a tendency for early post-seroconversion CD4 cell counts to change over calendar time.

Design: A prospective cohort study of individuals with well-estimated dates of seroconversion.

Methods: We studied 1251 individuals who seroconverted to HIV in Italy between 1985 and 2002, and for whom the first CD4 count was measured within 2 years of seroconversion and before any use of antiretrovirals. Linear regression models were used to assess evidence for a trend in post-seroconversion CD4 cell count over time.

Results: The median post-seroconversion CD4 cell count was 674 x 10 cells/l in those seroconverting between 1985 and 1990, 588 x 10 cells/l for 1991 to 1994, 559 x 10 cells/l for 1995 to 1998 and 494 x 10 cells/l for 1999 to 2002. The post-seroconversion CD4 cell count decreased by an average of 8.4 x 10 cells/l per year (95% confidence interval, 4.0-12.9; P < 0.001), after adjustment for potential confounders, including interval between HIV-negative and HIV-positive tests, lag time for first CD4 cell count measurement, age at seroconversion, gender, HIV-transmission group, and clinical centre. The finding was consistent in sensitivity analyses restricted to those with information on acute infection.

Conclusion: These data suggest a possible decreasing trend in CD4 cell count immediately following seroconversion in Italy which requires further investigation.

Citing Articles

Transmitted HIV-1 is more virulent in heterosexual individuals than men-who-have-sex-with-men.

James A, Dixit N PLoS Pathog. 2022; 18(3):e1010319.

PMID: 35271687 PMC: 8912199. DOI: 10.1371/journal.ppat.1010319.


The contribution of viral genotype to plasma viral set-point in HIV infection.

Hodcroft E, Hadfield J, Fearnhill E, Phillips A, Dunn D, OShea S PLoS Pathog. 2014; 10(5):e1004112.

PMID: 24789308 PMC: 4006911. DOI: 10.1371/journal.ppat.1004112.


Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Nomura S, Hosoya N, Brumme Z, Brockman M, Kikuchi T, Koga M J Virol. 2012; 87(3):1465-76.

PMID: 23152532 PMC: 3554148. DOI: 10.1128/JVI.02122-12.


The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Hogan C, DeGruttola V, Sun X, Fiscus S, Del Rio C, Hare C J Infect Dis. 2011; 205(1):87-96.

PMID: 22180621 PMC: 3242744. DOI: 10.1093/infdis/jir699.


Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Herbeck J, Muller V, Maust B, Ledergerber B, Torti C, Di Giambenedetto S AIDS. 2011; 26(2):193-205.

PMID: 22089381 PMC: 3597098. DOI: 10.1097/QAD.0b013e32834db418.